Understanding High-Frequency rTMS for Migraine
Migraines are not simply headaches. For millions of people, they are debilitating neurological events that disrupt work, social life, and basic daily functioning. Characterized by severe pain, nausea, light sensitivity, and fatigue, migraines can last hours or even days. While medications such as triptans, beta blockers, and anticonvulsants help many patients, a significant group continues to experience resistant or refractory migraines despite trying multiple therapies.
This treatment gap has driven interest in neuromodulation therapies, including repetitive transcranial magnetic stimulation (rTMS). In 2013, the U.S. Food and Drug Administration approved TMS as a noninvasive option for migraine, typically using a 10 Hz stimulation protocol. But not all patients respond to this standard approach. This has led researchers to explore whether high-frequency rTMS for migraine—delivered at 20 Hz—might provide better outcomes for those left behind by conventional options.
From 10 Hz to 20 Hz: Why Frequency Matters
The frequency of stimulation plays a crucial role in how rTMS affects brain activity. Lower frequencies, such as 1 Hz, are generally thought to reduce cortical excitability, while higher frequencies, such as 10 Hz or 20 Hz, increase it. Since migraine has been linked to abnormal excitability in cortical networks, fine-tuning stimulation frequency could directly influence outcomes.
A recent case series sheds light on this important distinction. Researchers followed five patients who had been living with migraines for an average of nearly 12 years. Each had failed multiple medications, and importantly, none had achieved meaningful relief from the standard 10 Hz rTMS protocol.
Instead of giving up, clinicians moved to a 20 Hz protocol. Patients received five sessions in the first week, followed by once-weekly treatments for four additional weeks. The shift in frequency produced a dramatic difference. Patients reported significant reductions in both frequency and intensity of migraine attacks. Even more encouraging, the benefits persisted for three to six months after treatment ended.
These findings suggest that high-frequency rTMS for migraine may succeed where traditional approaches fall short.
Mechanisms Behind High-Frequency Stimulation
Why would 20 Hz rTMS succeed where 10 Hz fails? While research is ongoing, several theories exist. High-frequency stimulation may more effectively engage brain regions involved in migraine pathophysiology, such as the dorsolateral prefrontal cortex and motor cortex. By modulating excitability in these networks, 20 Hz stimulation may reduce the abnormal cortical hyper-responsiveness thought to underlie chronic migraine.
Additionally, rTMS may influence the release of neurotransmitters like serotonin and dopamine, both of which are implicated in migraine. A higher stimulation frequency could amplify these effects, producing a more robust clinical response.
What This Means for Patients
For individuals who have cycled through medication after medication with little success, the possibility of relief from high-frequency rTMS for migraine is profoundly meaningful. Migraines often affect quality of life to a degree comparable to chronic conditions like diabetes or arthritis. Being offered an additional therapeutic option—especially one that is noninvasive and does not rely on daily drug intake—could be life changing.
Patients should be aware that these results are preliminary and based on a small group. However, the sustained improvement over several months highlights the potential of neuromodulation to reshape migraine care.
The Future of High-Frequency rTMS for Migraine
Although this case series represents only an early step, it points toward the need for well-designed randomized controlled trials. Future studies should examine larger patient populations, longer follow-up periods, and head-to-head comparisons between 10 Hz and 20 Hz protocols.
Researchers also need to identify which patients are most likely to respond. Factors such as migraine subtype (episodic vs chronic), comorbid conditions, or previous treatment history may all influence outcomes. If predictive markers can be identified, clinicians will be able to personalize therapy even further.
Conclusion
Migraines remain one of the most challenging neurological disorders to treat, especially in resistant cases. While medications and standard neuromodulation approaches help many, too many patients still live with persistent, disabling pain. The emergence of high-frequency rTMS for migraine provides new hope. By moving from 10 Hz to 20 Hz, clinicians may unlock meaningful and lasting relief for patients who had previously run out of options.
As the field of interventional psychiatry and neurology continues to evolve, one lesson is clear: the details matter. Something as simple as frequency adjustment may transform a treatment from ineffective to life-changing. For patients and clinicians alike, that is reason enough to be optimistic about the future of migraine care.
Learn more at https://interventionalpsychiatry.org/
References
- Khairkar P, Khoiwal R, Bamal I, et al. High-Frequency Repetitive Transcranial Magnetic Stimulation at 20 Hz: A Case Series Evaluating Efficacy in Treatment-Resistant Migraine After 10 Hz Repetitive Transcranial Magnetic Stimulation Failure. Pain Physician. 2025. PMID: 40900459
- Starling AJ. Noninvasive neuromodulation for migraine and cluster headache. Continuum (Minneap Minn). 2021;27(3):646-659. Link